This is the time of year when stocks are sleepy at best, and at worst, prone to pullbacks.

That's not necessarily true of all equities, however. Some groups are very active and perform quite well in the summer months. Pharmaceutical stocks - and especially biotech stocks - fare pretty well this time of year.

Part of that cyclical strength stems from how the Food and Drug Administration schedules key decision-making dates for new drugs. Another part of it may be the result of recurring industry conferences, where many drug-development updates are unveiled.

Here are 11 biotech stocks and pharmaceutical companies to watch over the next few months. Because biotechnology companies' shares tend to hinge heavily on product updates, this seasonal tide of news could move their respective stocks well before (and even long after) the day the news is posted. Just be cautious; smaller biotechnology stocks with one or just a couple of trial products can move drastically on new data - for better or for worse.

Alexion Pharmaceuticals

Neuromyelitis optica spectrum disorder (NMOSD) typically isn't discussed outside of the circles of people directly impacted by it. Indeed, most people struggle to retain and even say its full name.

But that relative obscurity is also the root of its opportunity.

Alexion Pharmaceuticals (, $121.30) is a specialty pharmaceuticals firm that is really coming into its own. Analysts expect sales growth of 15% this year, which